ascopubs.org

NRG-GU011: A phase II double-blinded, placebo-controlled trial of prostate oligometastatic radiotherapy with or without androgen deprivation therapy in oligometastatic prostate ...

A multi-center, open-label, randomized dose expansion study of PF-06821497, a potent and selective inhibitor of enhancer of zeste homolog 2 (EZH2), in patients with metastatic castration-resistant ...
Monthly Prescribing Reference

Irradiation Shows Lasting Results for Prostate Cancer Control

Study Supports IL16 Role in Prostate CA in African-Americans For men with prostate cancer, treatment with irradiation is associated with lasting prostate cancer control, defined as a prostate-specific ...
ascopubs.org

Controlling the Control Arm in Metastatic Castration-Resistant Prostate Cancer Trials: Best Standard of Care or the Minimum Standard of Care?

Testing for High-Risk Human Papillomavirus in Lower Genital Tract Tumors: If Knowledge Does Not Translate to an Action That Helps Patients—Why Do It? A substantial number of anticancer drugs receive ...
Science Daily

High-intensity focused ultrasound (HIFU) can control prostate cancer with fewer side effects

High-intensity focused ultrasound (HIFU) can help some men with prostate cancer avoid surgery or radiation. In recent years, a new treatment strategy known as focal therapy (partial gland ablation) ...